Viewing nowTelmicor 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.

MFDS item code 201903460 · Approved 2019.05.28 · Insurance code 054800280
Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients
This medication is used to treat essential hypertension. It also helps reduce the risk of myocardial infarction, stroke, and death from cardiovascular diseases in patients over 55 years old who are at high risk for cardiovascular diseases. It is particularly suitable for patients who cannot use ACE inhibitors. This medication is used to control blood pressure and protect cardiovascular health, thus improving the overall health status of the patient.
1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This drug produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of the risk of cardiovascular disease Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken regardless of meals. The risk-reduction effect on cardiovascular disease morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this drug to reduce the risk of cardiovascular disease, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm or death to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in individuals with hypersensitivity to it, in pregnant or nursing women, patients with severely impaired liver function, hereditary angioedema patients, and those with certain kidney diseases. Caution should be taken in elderly patients, patients with hyperkalemia, moderately impaired liver function, patients with heart valve diseases, gastrointestinal diseases, and those with severe kidney impairment. Various adverse reactions may occur during the use of this medication, including infections, blood disorders, allergic reactions, hyperkalemia, hypoglycemia, mental changes, dizziness, hypotension, respiratory symptoms, gastrointestinal symptoms, liver function abnormalities, skin rashes, myalgia, and kidney impairment; therefore, symptoms should be closely monitored. In particular, serious adverse reactions such as angioedema, hyperkalemia, renal dysfunction, shock, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, and if any abnormal symptoms appear, the medication should be stopped immediately and medical advice should be sought. Regular monitoring of serum potassium and creatinine levels is necessary in patients with renal impairment, and hypotension may occur if blood volume or sodium is deficient, thus requiring correction prior to administration. Additionally, this medication may have an increased effect when taken with other antihypertensive agents, and the risk of side effects may increase when used in combination with certain drugs, so it is essential to inform the physician or pharmacist of any other medications being taken. Women who are planning to become pregnant or who may become pregnant should avoid using this medication, and nursing mothers are also advised to refrain from use. Safety and effectiveness have not been established in children under 18 years of age, so it is not recommended. Elderly patients should be closely monitored for risks of excessive blood pressure reduction, which may lead to strokes and other complications during use. In cases of overdose, symptoms such as hypotension, abnormal heart rate, dizziness, and acute renal failure may occur, thus requiring immediate medical attention, as this medication is not removed by dialysis.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. Additionally, it should be stored at room temperature between 1 and 30 degrees Celsius for safe use.
White round tablet
Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.